COMBINATION MCL-1 INHIBITORS WITH ANTI-BODY DRUG CONJUGATES

The present disclosure generally relates to methods of treating cancer by administering an MCL-1 inhibitor and an antibody-drug conjugate.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kenney, Thomas F, Venkataramani, Chandrasekar, Matson, Clinton K
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure generally relates to methods of treating cancer by administering an MCL-1 inhibitor and an antibody-drug conjugate.